144 related articles for article (PubMed ID: 11063850)
1. What is the real target for ivermectin resistance selection in Onchocerca volvulus?
Grant W
Parasitol Today; 2000 Nov; 16(11):458-9; discussion 501-2. PubMed ID: 11063850
[No Abstract] [Full Text] [Related]
2. Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from Cameroon.
Nana-Djeunga HC; Bourguinat C; Pion SD; Bopda J; Kengne-Ouafo JA; Njiokou F; Prichard RK; Wanji S; Kamgno J; Boussinesq M
PLoS Negl Trop Dis; 2014 Apr; 8(4):e2824. PubMed ID: 24762816
[TBL] [Abstract][Full Text] [Related]
3. Population dynamics of onchocerca volvulus microfilariae in human host after six years of drug control.
Opara KN; Fagbemi BO
J Vector Borne Dis; 2008 Mar; 45(1):29-37. PubMed ID: 18399314
[TBL] [Abstract][Full Text] [Related]
4. Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment.
Bourguinat C; Pion SD; Kamgno J; Gardon J; Duke BO; Boussinesq M; Prichard RK
PLoS Negl Trop Dis; 2007 Aug; 1(1):e72. PubMed ID: 17989786
[TBL] [Abstract][Full Text] [Related]
5. A Reevaluation of the Tolerability and Effects of Single-Dose Ivermectin Treatment on Onchocerca volvulus Microfilariae in the Skin and Eyes in Eastern Ghana.
Opoku NO; Gyasi ME; Doe F; Lew D; Hong AR; Chithenga S; Fischer PU; King CL; Weil GJ
Am J Trop Med Hyg; 2021 Nov; 106(2):740-745. PubMed ID: 34844204
[TBL] [Abstract][Full Text] [Related]
6. Ivermectin resistance in Onchocerca volvulus: toward a genetic basis.
Lustigman S; McCarter JP
PLoS Negl Trop Dis; 2007 Aug; 1(1):e76. PubMed ID: 17989789
[No Abstract] [Full Text] [Related]
7. Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin.
Pion SD; Grout L; Kamgno J; Nana-Djeunga H; Boussinesq M
Acta Trop; 2011 Sep; 120 Suppl 1():S91-9. PubMed ID: 20497765
[TBL] [Abstract][Full Text] [Related]
8. Ivermectin selection on beta-tubulin: evidence in Onchocerca volvulus and Haemonchus contortus.
Eng JK; Blackhall WJ; Osei-Atweneboana MY; Bourguinat C; Galazzo D; Beech RN; Unnasch TR; Awadzi K; Lubega GW; Prichard RK
Mol Biochem Parasitol; 2006 Dec; 150(2):229-35. PubMed ID: 17007942
[TBL] [Abstract][Full Text] [Related]
9. Modeling targeted ivermectin treatment for controlling river blindness.
Poolman EM; Galvani AP
Am J Trop Med Hyg; 2006 Nov; 75(5):921-7. PubMed ID: 17123988
[TBL] [Abstract][Full Text] [Related]
10. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
[TBL] [Abstract][Full Text] [Related]
11. Reduction in the prevalence and intensity of infection in Onchocerca volvulus microfilariae according to ethnicity and community after 8 years of ivermectin treatment on the island of Bioko, Equatorial Guinea.
Mas J; Ascaso C; Escaramis G; Abellana R; Duran E; Sima A; Sánchez MJ; Nkogo PR; Nguema R; Untoria MD; Echeverria MA; Ardevol MM; de Jiménez Anta MT
Trop Med Int Health; 2006 Jul; 11(7):1082-91. PubMed ID: 16827709
[TBL] [Abstract][Full Text] [Related]
12. A randomized, single-ascending-dose, ivermectin-controlled, double-blind study of moxidectin in Onchocerca volvulus infection.
Awadzi K; Opoku NO; Attah SK; Lazdins-Helds J; Kuesel AC
PLoS Negl Trop Dis; 2014 Jun; 8(6):e2953. PubMed ID: 24968000
[TBL] [Abstract][Full Text] [Related]
13. Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms.
Duke BO
Parasitology; 2005 Apr; 130(Pt 4):447-53. PubMed ID: 15830819
[TBL] [Abstract][Full Text] [Related]
14. Onchocerca volvulus and O. lienalis: the microfilaricidal activity of moxidectin compared with that of ivermectin in vitro and in vivo.
Tagboto SK; Townson S
Ann Trop Med Parasitol; 1996 Oct; 90(5):497-505. PubMed ID: 8915126
[TBL] [Abstract][Full Text] [Related]
15. The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus.
Awadzi K; Edwards G; Duke BO; Opoku NO; Attah SK; Addy ET; Ardrey AE; Quartey BT
Ann Trop Med Parasitol; 2003 Mar; 97(2):165-78. PubMed ID: 12803872
[TBL] [Abstract][Full Text] [Related]
16. Immunohistological studies on an Onchocerca volvulus ankyrin (EI).
Erttmann KD; Gallin MY; Eggert P; Büttner DW
Trop Med Int Health; 1996 Oct; 1(5):558-74. PubMed ID: 8911440
[TBL] [Abstract][Full Text] [Related]
17. Elimination of human onchocerciasis: history of progress and current feasibility using ivermectin (Mectizan(®)) monotherapy.
Cupp EW; Sauerbrey M; Richards F
Acta Trop; 2011 Sep; 120 Suppl 1():S100-8. PubMed ID: 20801094
[TBL] [Abstract][Full Text] [Related]
18. The chemotherapy of onchocerciasis XX: ivermectin in combination with albendazole.
Awadzi K; Addy ET; Opoku NO; Plenge-Bönig A; Büttner DW
Trop Med Parasitol; 1995 Dec; 46(4):213-20. PubMed ID: 8826100
[TBL] [Abstract][Full Text] [Related]
19. Differential susceptibility of Onchocerca volvulus microfilaria to ivermectin in two areas of contrasting history of mass drug administration in Cameroon: relevance of microscopy and molecular techniques for the monitoring of skin microfilarial repopulation within six months of direct observed treatment.
Abong RA; Amambo GN; Chounna Ndongmo PW; Njouendou AJ; Ritter M; Beng AA; Esum ME; Deribe K; Fru-Cho J; Fombad FF; Nji TM; Enyong PI; Poole CB; Pfarr K; Hoerauf A; Carlow CKS; Wanji S
BMC Infect Dis; 2020 Oct; 20(1):726. PubMed ID: 33008333
[TBL] [Abstract][Full Text] [Related]
20. The life and times of ivermectin - a success story.
Omura S; Crump A
Nat Rev Microbiol; 2004 Dec; 2(12):984-9. PubMed ID: 15550944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
